An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

被引:0
|
作者
Joan Jacob
Liezl E. Francisco
Treena Chatterjee
Zhengdong Liang
Shraddha Subramanian
Qingyun J. Liu
Julie H. Rowe
Kendra S. Carmon
机构
[1] University of Texas Health Science Center at Houston,Center for Translational Cancer Research, The Brown Foundation Institute of Molecular Medicine
[2] University of Texas Health Science Center at Houston,Department of Internal Medicine, McGovern Medical School
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1592 / 1602
页数:10
相关论文
共 50 条
  • [41] Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models
    Whiteman, Kathleen R.
    Johnson, Holly A.
    Mayo, Michele F.
    Audette, Charlene A.
    Carrigan, Christina N.
    LaBelle, Alyssa
    Zukerberg, Lawrence
    Lambert, John M.
    Lutz, Robert J.
    MABS, 2014, 6 (02) : 556 - 566
  • [42] BCG033, a novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, demonstrates preclinical efficacy against triple-negative breast cancer and other solid tumor xenografts
    Yao, Sufei
    Shang, Chengzhang
    An, Gao
    Guo, Chaoshe
    An, W. Frk
    Yang, Yi
    CANCER RESEARCH, 2024, 84 (06)
  • [43] Antibody-drug conjugate targeting tissue factor for pancreatic cancer treatment
    Tsumura, Ryo
    Anzai, Takahiro
    Manabe, Shino
    Takashima, Hiroki
    Koga, Yoshikatsu
    Yasunaga, Masahiro
    Matsumura, Yasuhiro
    CANCER SCIENCE, 2021, 112 : 725 - 725
  • [44] A Traceless Vascular-Targeting Antibody-Drug Conjugate for Cancer Therapy
    Bernardes, Goncalo J. L.
    Casi, Giulio
    Truessel, Sabrina
    Hartmann, Isabelle
    Schwager, Kathrin
    Scheuermann, Joerg
    Neri, Dario
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (04) : 941 - 944
  • [45] An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
    Juan Carlos Montero
    Sofía del Carmen
    Mar Abad
    José M. Sayagués
    Antonio Barbáchano
    Asunción Fernández-Barral
    Alberto Muñoz
    Atanasio Pandiella
    Journal of Experimental & Clinical Cancer Research, 42
  • [46] MONOCLONAL ANTIBODY-DRUG CONJUGATE THERAPY FOR THE PATIENTS WITH COLORECTAL-CANCER
    TAKAHASHI, T
    YAMAGUCHI, T
    KITAMURA, K
    NOGUCHI, A
    HONDA, M
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 168 (02): : 371 - 374
  • [47] In vivo efficacy of the carbonic anhydrase IX (CA9)-targeted antibody-drug conjugate BAY 79-4620 is superior to that of microtubule inhibitors in preclinical models of NSCLC, gastric and colorectal cancer
    Petrul, Heike
    Kopitz, Charlotte
    Schatz, Christoph
    Beier, Rudolf
    Zatovicova, Miriam
    Pastorekova, Silvia
    Kreft, Bertolt
    Ziegelbauer, Karl
    CANCER RESEARCH, 2011, 71
  • [48] Efficacy of the Antibody-Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors
    Akla, Barbara
    Broussas, Matthieu
    Loukili, Noureddine
    Robert, Alain
    Beau-Larvor, Charlotte
    Malissard, Martine
    Boute, Nicolas
    Champion, Thierry
    Haeuw, Jean-Francois
    Beck, Alain
    Perez, Michel
    Dreyfus, Cyrille
    Pavlyuk, Mariya
    Chetaille, Eric
    Corvaia, Nathalie
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 168 - 177
  • [49] Targeting the MAP Kinase and Wnt Signaling Pathways in Preclinical Models of Colorectal Cancer
    Spreafico, A.
    Klauck, P. J.
    Tentler, J. J.
    Pitts, T. M.
    Tan, A. C.
    Kim, J.
    Gregory, M. A.
    McManus, M. C.
    Arcaroli, J. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 150 - 150
  • [50] Preclinical development of a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer
    Son, Thomas
    Scribner, Juniper A.
    Hooley, Jeff
    Chiechi, Michael
    Li, Pam
    Hotaling, Timothy E.
    De Costa, Anushka
    Chen, Yan
    Chen, Francine
    Barat, Bhaswati
    Ciccarone, Valentina
    Gaynutdinov, Timur
    Tamura, James
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2017, 77